Results 31 to 40 of about 461,852 (357)

Should Chemotherapy Be Administered for Essential Thrombocythemia (ET) Patients with Leukemic Transformation?

Proceedings of Singapore Healthcare, 2011
Introduction: Essential Thrombocythemia (ET) is a clonal myeloproliferative disease presenting predominantly with thrombocytosis. One of its rare complications is leukemic transformation (LT). Once leukemic transformation occurs, prognosis is dismal.
Gee Chuan Wong FRCP, FAMS(Hematology)
doaj   +1 more source

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Blood Advances, 2018
BACKGROUND Venous thromboembolism (VTE) is the third most common vascular disease. Medical inpatients, long-term care residents, persons with minor injuries, and long-distance travelers are at increased risk.
H. Schünemann, M. Cushman, Allison E. Burnett, S. Kahn, J. Beyer-Westendorf, F. Spencer, S. Rezende, N. Zakai, K. Bauer, F. Dentali, Jill Lansing, S. Balduzzi, A. Darzi, G. P. Morgano, I. Neumann, R. Nieuwlaat, J. Yepes‐Nuñez, Yuan Zhang, W. Wiercioch   +18 more
semanticscholar   +1 more source

Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters

Annals of Translational Medicine, 2020
Background The third fatal coronavirus is the novel coronavirus (SARS-CoV-2) that causes novel coronavirus pneumonia (COVID-19) which first broke out in December 2019.
Changzheng Wang, Rongrong Deng, Liyao Gou, Z. Fu, Xiaomei Zhang, F. Shao, Guanzheng Wang, Weiyang Fu, Jianping Xiao, X. Ding, Tao Li, Xi-sheng Xiao, Chengbin Li   +12 more
semanticscholar   +1 more source

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)

Annals of Hematology, 2021
Hematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii pneumonia (PcP).
Annika Y. Classen, L. Henze, M. von Lilienfeld-Toal, G. Maschmeyer, M. Sandherr, Luisa Durán Graeff, N. Alakel, M. Christopeit, S. Krause, K. Mayer, S. Neumann, O. Cornely, O. Penack, F. Weissinger, H. Wolf, J. Vehreschild   +15 more
semanticscholar   +1 more source

Hematology

Southern Medical Journal, 1946
Mode of access: Internet.
openaire   +2 more sources

Determinants of hematology-oncology trainees' postfellowship career pathways with a focus on nonmalignant hematology

Blood Advances, 2018
: Nonmalignant hematologic conditions are extremely prevalent and contribute significantly to the global burden of disease. The US health care system may soon face a shortage of specialists in nonmalignant hematology.
Ariela L. Marshall, Sarah Jenkins, Joseph Mikhael, Scott D. Gitlin   +3 more
doaj   +1 more source

The European Hematology Association Roadmap for European Hematology Research: a consensus document

Haematologica, 2016
The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable ...
Andreas Engert, Carlo Balduini, Anneke Brand, Bertrand Coiffier, Catherine Cordonnier, Hartmut Döhner, Thom Duyvené de Wit, Sabine Eichinger, Willem Fibbe, Tony Green, Fleur de Haas, Achille Iolascon, Thierry Jaffredo, Francesco Rodeghiero, Gilles Salles, Jan Jacob Schuringa, the other authors of the EHA Roadmap for European Hematology Research   +16 more
doaj   +1 more source

The Effect of Probiotic Doses in Biofloc Growth on Hematological and Histological Status of Catfish

Journal of Experimental Life Science, 2023
Biofloc technology is one of the promising methods to overcome water quality problems in fish farming. This technology uses an environmentally friendly approach and does not harm cultivated organisms.
Guilherme Teotonio Gomes, Sri Andayani, Uun Yanuhar   +2 more
doaj   +1 more source

American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.

Blood Advances, 2020
BACKGROUND Older adults with acute myeloid leukemia (AML) represent a vulnerable population in whom disease-based and clinical risk factors, patient goals, prognosis, and practitioner- and patient-perceived treatment risks and benefits influence ...
M. Sekeres, G. Guyatt, G. Abel, S. Alibhai, J. Altman, R. Buckstein, H. Choe, Pinkal M. Desai, H. Erba, C. Hourigan, T. Leblanc, M. Litzow, J. MacEachern, L. Michaelis, S. Mukherjee, K. O'Dwyer, A. Rosko, R. Stone, A. Agarwal, L. Colunga-Lozano, L. Colunga-Lozano, Yaping Chang, Qiu Kui Hao, Qiu Kui Hao, R. Brignardello-Petersen   +24 more
semanticscholar   +1 more source

Hematologic malignancies

Current Opinion in Hematology, 2001
Abstract This article reviews highlights in the field of hematologic malignancies presented at the 2001 annual meeting of the American Society of Clinical Oncology. Targeted therapies continue to proceed from the laboratory to the clinic.
M, Petryk, M L, Grossbard
openaire   +4 more sources